With specialty drugs accounting for roughly half of total drug spending, employers continue to grapple with the high-cost therapies.
According to a report from the Pharmacy Benefit Management Institute (PBMI), employers are taking an increased interest in not only drug adherence, but also whether medicines are being used appropriately.
Outcomes-based contracts, according to an American Journal of Managed Care (AJMC) report, can facilitate the tracking of patient outcomes.
“Timely, accurate, and actionable reporting is key to measuring how a plan is doing in terms of specialty drug benefit management,” PBMI’s report states. “When done well, reporting can highlight areas of opportunity to improve clinical and financial outcomes.”
To read more on AJMC, click here.